home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Technology Approaches to Improve Patient Enrollment in Decentralized Clinical Trials

 
  March 28, 2022  
     
 


xtalks.com, webinar
Monday, April 04, 2022 | 11am EDT (NA) / 4pm BST (UK) / 5pm CEST (EU-Central)


Who Should Attend?

Senior professionals, including clinical data managers, clinical project managers and study managers, who are working in:

  • Digital Therapeutics
  • Clinical Operations
  • Clinical Research
  • Research and Development
  • Scientific Affairs

What You Will Learn

  • Leverage technology to expand access to clinical research
  • Increase transparency of patient enrollment to lower costs and increase efficiencies
  • Reduce site burden with real-time analytics to quickly move patients through the enrollment process
 
 
Organized by: xtalks.com
Invited Speakers:

Speakers

http://Martin%20Kilsgård,%20Trialbee

Martin Kilsgård, Head of Product, Trialbee

Martin has worked within software development and digital transformation for almost 15 years. He has held various leadership positions within digital product management and has a proven track record as a key strategist, coach and innovator. Martin has broad experience from large global organizations as well as small start-ups. Before joining Trialbee, Martin worked within the life sciences industry, initially as Product Manager at the telehealth provider Docly and as a Senior Business Consultant at CGI (digitalizing government healthcare in Sweden). Martin holds a Master of Science in Electrical Engineering from Lund’s University (Sweden) and is a certified Product Owner (Scrum Alliance).

Message Presenter
http://Kimberly%20Tableman,%20Castor

Kimberly Tableman, Chief Clinical Development Officer, Castor

Kimberly Tableman is Chief Clinical Development Officer (CCDO) at Castor. She has more than 23 years of experience in clinical development and technology. Over the past decade, she has focused on applying digital health technologies to reimagine the patient journey. She was most recently CEO at Medicine X, and co-founder at Rabble Health, where she led the development and beta launch of a patient engagement platform to serve oncology patients. Prior to Medicine X, Kimberly held senior roles at GlaxoSmithKline (GSK), including Head of Patient Engagement and Head of Digital Clinical Trials. She has also worked at Pfizer, and began her career in management consulting at Cap Gemini Ernst & Young.

 
Deadline for Abstracts: na
 
Registration: https://xtalks.com/webinars/technology-approaches-to-improve-patient-enrollment-in-decentralized-clinical-trials/
E-mail: shunte@xtalks.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.